Disparities in Post-Acute Stroke Care Depend on Insurance Status
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
WEDNESDAY, July 17, 2024 -- Insurance-dependent racial and ethnic disparities and regional variations are seen in post-acute service utilization after stroke, according to a study published online July 17 in Neurology: Clinical Practice.
Shumei Man, M.D., Ph.D., from the Neurological Institute at the Cleveland Clinic, and colleagues conducted a retrospective cross-sectional study involving patients hospitalized for ischemic stroke and intracerebral hemorrhage in 2017 to 2018 using the National Inpatient Sample. Data were included for 1,000,980 weighted ischemic stroke admissions.
The researchers found that uninsured patients had the lowest adjusted odds of facility over home discharge and home health care (HHC) discharge over home without HHC (odds ratios, 0.44 and 0.79, respectively) compared with patients with private insurance. Only Hispanic patients with Medicare/Medicaid insurance or self-pay had lower odds of facility over home discharge compared with White patients (adjusted odds ratios, 0.80 and 0.75, respectively). Lower odds of HHC discharge over home without HHC discharge were seen for uninsured Hispanic patients versus White patients (adjusted odds ratio, 0.74). The HHC discharge rate was highest in the East North Central region and lowest in the Pacific region (39.2 and 31.2 percent, respectively). The HHC discharge rate was highest in New England and lowest in the West North Central region (20.2 and 10.3 percent, respectively).
"These findings indicate that targeted efforts are needed to improve access to care after stroke for people without insurance, especially Hispanic people, as well as those in specific regions to ensure optimal recovery and successful community transition for all people across the country," Man said in a statement.
One author disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-07-18 07:15
Read more
- Alcohol-Induced Liver Disease Hospitalizations, Transplants on the Rise
- Beta Blockers May Cause Depressive Symptoms
- First U.S. Case of New Mpox Strain Spotted in Traveler
- AI Analysis of Video Can ID Neurologic Changes in the NICU
- Two-Fifths of Americans Say They Experience the 'Winter Blues'
- Shorla Oncology Announces U.S. FDA Expanded Approval of Jylamvo (methotrexate), an Oncology and Autoimmune Drug for Pediatric Indications
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions